Human T-cell lymphotropic virus type 1 (HTLV-1) proposed vaccines: a systematic review of preclinical and clinical studies

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

Extent: Online-Ressource, 1 online resource.

Language: Englisch

Bibliographic citation: Human T-cell lymphotropic virus type 1 (HTLV-1) proposed vaccines: a systematic review of preclinical and clinical studies ; volume:23 ; number:1 ; day:11 ; month:5 ; year:2023 ; pages:1-41 ; date:12.2023
BMC infectious diseases ; 23, Heft 1 (11.5.2023), 1-41, 12.2023

Creator: Seighali, Niloofar
Shafiee, Arman
Rafiee, Mohammad Ali
Aminzade, Dlnya
Mozhgani, Sayed-Hamidreza

Contributor: SpringerLink (Online service)

DOI: 10.1186/s12879-023-08289-7

URN: urn:nbn:de:101:1-2023090713143736087850

Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 14.08.2025, 10:44 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Seighali, Niloofar
Shafiee, Arman
Rafiee, Mohammad Ali
Aminzade, Dlnya
Mozhgani, Sayed-Hamidreza
SpringerLink (Online service)

Other Objects (12)

Targeting HTLV-I latency in Adult T-cell Leukemia/Lymphoma

Control of ROS production and T-cell turnover by HTLV-p13

Ensuring equity with pre-clinical planning for chlamydia vaccines

Human T-cell leukemia virus type I (HTLV-I) infection and the onset of adult T-cell leukemia (ATL)

Retinal manifestations in adult T-cell leukemia/lymphoma virus type 1 (HTLV-1)

Amphiphilic Cyclodextrin‐Based Nanoparticulate Vaccines Can Trigger T‐Cell Immune Responses

Predicting population coverage of T-cell epitope-based diagnostics and vaccines

Cancer DNA vaccines: current preclinical and clinical developments and future perspectives

Preclinical immunogenicity and safety of hemagglutinin-encoding modRNA influenza vaccines

Preclinical safety and immunogenicity of Streptococcus pyogenes (Strep A) peptide vaccines

P17-26. Effective design of T-cell driven vaccines applied to the GAIA HIV vaccine: advances in vaccine design based on current preclinical success

Epidemiology of Human T-cell lymphotropic viruses (HTLV) in England and Wales, 2003-2012

Targeting HTLV-I latency in Adult T-cell Leukemia/Lymphoma

Control of ROS production and T-cell turnover by HTLV-p13

Ensuring equity with pre-clinical planning for chlamydia vaccines

Human T-cell leukemia virus type I (HTLV-I) infection and the onset of adult T-cell leukemia (ATL)

Retinal manifestations in adult T-cell leukemia/lymphoma virus type 1 (HTLV-1)

Amphiphilic Cyclodextrin‐Based Nanoparticulate Vaccines Can Trigger T‐Cell Immune Responses

Predicting population coverage of T-cell epitope-based diagnostics and vaccines

Cancer DNA vaccines: current preclinical and clinical developments and future perspectives

Preclinical immunogenicity and safety of hemagglutinin-encoding modRNA influenza vaccines

Preclinical safety and immunogenicity of Streptococcus pyogenes (Strep A) peptide vaccines

P17-26. Effective design of T-cell driven vaccines applied to the GAIA HIV vaccine: advances in vaccine design based on current preclinical success

Epidemiology of Human T-cell lymphotropic viruses (HTLV) in England and Wales, 2003-2012

Targeting HTLV-I latency in Adult T-cell Leukemia/Lymphoma

Control of ROS production and T-cell turnover by HTLV-p13

Ensuring equity with pre-clinical planning for chlamydia vaccines

Human T-cell leukemia virus type I (HTLV-I) infection and the onset of adult T-cell leukemia (ATL)

Retinal manifestations in adult T-cell leukemia/lymphoma virus type 1 (HTLV-1)

Amphiphilic Cyclodextrin‐Based Nanoparticulate Vaccines Can Trigger T‐Cell Immune Responses

Predicting population coverage of T-cell epitope-based diagnostics and vaccines

Cancer DNA vaccines: current preclinical and clinical developments and future perspectives

Preclinical immunogenicity and safety of hemagglutinin-encoding modRNA influenza vaccines

Preclinical safety and immunogenicity of Streptococcus pyogenes (Strep A) peptide vaccines

P17-26. Effective design of T-cell driven vaccines applied to the GAIA HIV vaccine: advances in vaccine design based on current preclinical success

Epidemiology of Human T-cell lymphotropic viruses (HTLV) in England and Wales, 2003-2012

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Human T-cell lymphotropic virus type 1 (HTLV-1) proposed vaccines: a systematic review of preclinical and clinical studies

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Targeting HTLV-I latency in Adult T-cell Leukemia/Lymphoma

Control of ROS production and T-cell turnover by HTLV-p13

Ensuring equity with pre-clinical planning for chlamydia vaccines

Human T-cell leukemia virus type I (HTLV-I) infection and the onset of adult T-cell leukemia (ATL)

Retinal manifestations in adult T-cell leukemia/lymphoma virus type 1 (HTLV-1)

Amphiphilic Cyclodextrin‐Based Nanoparticulate Vaccines Can Trigger T‐Cell Immune Responses

Predicting population coverage of T-cell epitope-based diagnostics and vaccines

Cancer DNA vaccines: current preclinical and clinical developments and future perspectives

Preclinical immunogenicity and safety of hemagglutinin-encoding modRNA influenza vaccines

Preclinical safety and immunogenicity of Streptococcus pyogenes (Strep A) peptide vaccines

P17-26. Effective design of T-cell driven vaccines applied to the GAIA HIV vaccine: advances in vaccine design based on current preclinical success

Epidemiology of Human T-cell lymphotropic viruses (HTLV) in England and Wales, 2003-2012

Targeting HTLV-I latency in Adult T-cell Leukemia/Lymphoma

Control of ROS production and T-cell turnover by HTLV-p13

Ensuring equity with pre-clinical planning for chlamydia vaccines

Human T-cell leukemia virus type I (HTLV-I) infection and the onset of adult T-cell leukemia (ATL)

Retinal manifestations in adult T-cell leukemia/lymphoma virus type 1 (HTLV-1)

Amphiphilic Cyclodextrin‐Based Nanoparticulate Vaccines Can Trigger T‐Cell Immune Responses

Predicting population coverage of T-cell epitope-based diagnostics and vaccines

Cancer DNA vaccines: current preclinical and clinical developments and future perspectives

Preclinical immunogenicity and safety of hemagglutinin-encoding modRNA influenza vaccines

Preclinical safety and immunogenicity of Streptococcus pyogenes (Strep A) peptide vaccines

P17-26. Effective design of T-cell driven vaccines applied to the GAIA HIV vaccine: advances in vaccine design based on current preclinical success

Epidemiology of Human T-cell lymphotropic viruses (HTLV) in England and Wales, 2003-2012

Targeting HTLV-I latency in Adult T-cell Leukemia/Lymphoma

Control of ROS production and T-cell turnover by HTLV-p13

Ensuring equity with pre-clinical planning for chlamydia vaccines

Human T-cell leukemia virus type I (HTLV-I) infection and the onset of adult T-cell leukemia (ATL)

Retinal manifestations in adult T-cell leukemia/lymphoma virus type 1 (HTLV-1)

Amphiphilic Cyclodextrin‐Based Nanoparticulate Vaccines Can Trigger T‐Cell Immune Responses

Predicting population coverage of T-cell epitope-based diagnostics and vaccines

Cancer DNA vaccines: current preclinical and clinical developments and future perspectives

Preclinical immunogenicity and safety of hemagglutinin-encoding modRNA influenza vaccines

Preclinical safety and immunogenicity of Streptococcus pyogenes (Strep A) peptide vaccines

P17-26. Effective design of T-cell driven vaccines applied to the GAIA HIV vaccine: advances in vaccine design based on current preclinical success

Epidemiology of Human T-cell lymphotropic viruses (HTLV) in England and Wales, 2003-2012

Related objects

Reset password